US 8951527
Radioprotectants targeting thrombospondin-1 and CD47
granted A61KA61K2039/505A61K38/39
Quick answer
US patent 8951527 (Radioprotectants targeting thrombospondin-1 and CD47) held by The United States of America, as represented by the Secretary, Department of Health and Human Services expires Mon Feb 05 2035 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The United States of America, as represented by the Secretary, Department of Health and Human Services
- Grant date
- Tue Feb 10 2015 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Feb 05 2035 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 21
- CPC classes
- A61K, A61K2039/505, A61K38/39, A61P, A61P35/00